DocGo (NASDAQ:DCGO – Get Free Report) and CochLear (OTCMKTS:CHEOY – Get Free Report) are both medical companies, but which is the better investment? We will contrast the two businesses based on the strength of their analyst recommendations, dividends, earnings, profitability, institutional ownership, valuation and risk.
Analyst Recommendations
This is a summary of recent ratings and recommmendations for DocGo and CochLear, as reported by MarketBeat.
| Sell Ratings | Hold Ratings | Buy Ratings | Strong Buy Ratings | Rating Score | |
| DocGo | 1 | 3 | 3 | 0 | 2.29 |
| CochLear | 0 | 2 | 1 | 2 | 3.00 |
DocGo presently has a consensus target price of $2.38, suggesting a potential upside of 316.67%. Given DocGo’s higher probable upside, equities analysts clearly believe DocGo is more favorable than CochLear.
Insider & Institutional Ownership
Profitability
This table compares DocGo and CochLear’s net margins, return on equity and return on assets.
| Net Margins | Return on Equity | Return on Assets | |
| DocGo | -56.61% | -34.41% | -23.82% |
| CochLear | N/A | N/A | N/A |
Risk & Volatility
DocGo has a beta of 0.98, meaning that its stock price is 2% less volatile than the S&P 500. Comparatively, CochLear has a beta of 1.14, meaning that its stock price is 14% more volatile than the S&P 500.
Earnings and Valuation
This table compares DocGo and CochLear”s revenue, earnings per share and valuation.
| Gross Revenue | Price/Sales Ratio | Net Income | Earnings Per Share | Price/Earnings Ratio | |
| DocGo | $322.20 million | 0.17 | -$182.40 million | ($1.85) | -0.31 |
| CochLear | $1.53 billion | 5.20 | $251.85 million | N/A | N/A |
CochLear has higher revenue and earnings than DocGo.
Summary
CochLear beats DocGo on 9 of the 13 factors compared between the two stocks.
About DocGo
DocGo Inc. provides mobile health and medical transportation services for various health care providers in the United States and the United Kingdom. The company's transportation services include emergency response services; and non-emergency transport services comprise ambulance and wheelchair transportation services. It also offers mobile health services through its platform that are performed at home, offices, and other locations; event services, which include on-site healthcare support at sporting events and concerts; and total care management solutions comprising healthcare services and ancillary services, such as shelter. DocGo Inc. was founded in 2015 and is headquartered in New York, New York.
About CochLear
Cochlear Limited provides implantable hearing solutions for children and adults worldwide. It offers cochlear implant systems, sound processor upgrades, bone conduction systems, accessories, and other products. Cochlear Limited was founded in 1981 and is headquartered in Sydney, Australia.
Receive News & Ratings for DocGo Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for DocGo and related companies with MarketBeat.com's FREE daily email newsletter.
